Diapharm makes changes to senior management team

Ralf Sibbing continues as General Manager while Martin Vortkamp leaves the company

Pharmaceutical service provider Diapharm, headquartered in Münster, Germany, is restructuring its senior management. Ralf Sibbing will continue as sole General Manager. Martin Vortkamp will leave the company by mutual agreement.

Diapharm founder Dr Stefan Sandner said there had been a difference in opinion regarding the strategic focus of Diapharm as a leading service provider and consulting firm for the consumer healthcare and pharmaceutical industry. Vortkamp joined Diapharm in 2009 and held a variety of positions at the company before being named Co-General Manager in 2012.

Founded in 1988, Diapharm supports and advises companies from the pharmaceutical and healthcare industry on regulatory, medical, pharmaceutical and quality assurance matters. The company employs more than 100 people at locations in Germany, Austria, the UK and China.

You may also like

Regulatory

Diapharm authorised to assist medical device registration in Switzerland

Procedural changes were made in May 2021 in relation to the marketing and distribution of medical devices in Switzerland
Regulatory

Diapharm becomes European Authorised Representative

Companies based outside the EU that want to market their products in it must appoint a representative. Diapharm has been certified as such for medical devices
Regulatory

US Pharmacopeia details mass spectrometry guidelines to advance biologics impurity control

The new chapter aims to standardise the use of mass spectrometry-based analysis in the biopharmaceutical industry, which can be used to detect impurities in cell and gene therapies, antibodies and other biologics
Regulatory

Merck's Welireg approved for cancers associated with von Hippel-Lindau disease in China

The once-daily drug is the first HIF-2α to be approved in China, exhibiting a 49% objective response rate (ORR)
Manufacturing

Vetter strengthens senior management team for growth

Three new managing directors to support global sustainable development
Manufacturing

IMed Consultancy helps Toby Orthopaedics navigate UK regulations

Regulatory consultancy ensures compliance and confidence for Miami-based company
Manufacturing

Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority

The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
Subscribe now